ATE408841T1 - Assay zum nachweis von glykiertem oder glykosyliertem hämoglobin (hba1c) - Google Patents

Assay zum nachweis von glykiertem oder glykosyliertem hämoglobin (hba1c)

Info

Publication number
ATE408841T1
ATE408841T1 AT05254842T AT05254842T ATE408841T1 AT E408841 T1 ATE408841 T1 AT E408841T1 AT 05254842 T AT05254842 T AT 05254842T AT 05254842 T AT05254842 T AT 05254842T AT E408841 T1 ATE408841 T1 AT E408841T1
Authority
AT
Austria
Prior art keywords
glycated
detection
assay
hba1c
glycosylated hemoglobin
Prior art date
Application number
AT05254842T
Other languages
English (en)
Inventor
Ken Milne
Margaret Lawlor
Original Assignee
Axis Shield Diagnostics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0417212A external-priority patent/GB0417212D0/en
Priority claimed from GB0507955A external-priority patent/GB0507955D0/en
Application filed by Axis Shield Diagnostics Ltd filed Critical Axis Shield Diagnostics Ltd
Application granted granted Critical
Publication of ATE408841T1 publication Critical patent/ATE408841T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT05254842T 2004-08-03 2005-08-03 Assay zum nachweis von glykiertem oder glykosyliertem hämoglobin (hba1c) ATE408841T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59851104P 2004-08-03 2004-08-03
GB0417212A GB0417212D0 (en) 2004-08-03 2004-08-03 Assay
GB0507955A GB0507955D0 (en) 2005-04-20 2005-04-20 Assay

Publications (1)

Publication Number Publication Date
ATE408841T1 true ATE408841T1 (de) 2008-10-15

Family

ID=35432325

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05254842T ATE408841T1 (de) 2004-08-03 2005-08-03 Assay zum nachweis von glykiertem oder glykosyliertem hämoglobin (hba1c)

Country Status (7)

Country Link
US (1) US7592182B2 (de)
EP (1) EP1624307B1 (de)
JP (1) JP5031208B2 (de)
AT (1) ATE408841T1 (de)
AU (1) AU2005203321A1 (de)
CA (1) CA2514010A1 (de)
DE (1) DE602005009769D1 (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
AU2002348683A1 (en) 2001-06-12 2002-12-23 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US7041068B2 (en) 2001-06-12 2006-05-09 Pelikan Technologies, Inc. Sampling module device and method
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
WO2002100460A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Electric lancet actuator
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
CA2448902C (en) 2001-06-12 2010-09-07 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7892185B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
EP2238892A3 (de) 2003-05-30 2011-02-09 Pelikan Technologies Inc. Vorrichtung zur Entnahme von Körperflüssigkeit
ES2490740T3 (es) 2003-06-06 2014-09-04 Sanofi-Aventis Deutschland Gmbh Aparato para toma de muestras de fluido sanguíneo y detección de analitos
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
EP1671096A4 (de) 2003-09-29 2009-09-16 Pelikan Technologies Inc Verfahren und apparatur für eine verbesserte probeneinfangvorrichtung
EP1680014A4 (de) 2003-10-14 2009-01-21 Pelikan Technologies Inc Verfahren und gerät für eine variable anwenderschnittstelle
WO2005065414A2 (en) * 2003-12-31 2005-07-21 Pelikan Technologies, Inc. Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
EP1765194A4 (de) 2004-06-03 2010-09-29 Pelikan Technologies Inc Verfahren und gerät für eine flüssigkeitsentnahmenvorrichtung
US8652831B2 (en) * 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
WO2006112339A1 (ja) * 2005-04-14 2006-10-26 Matsushita Electric Industrial Co., Ltd. ヘモグロビン誘導体の測定方法、それに用いる試薬組成物、測定キット、分析デバイス、及び分析システム
WO2007117794A2 (en) * 2006-03-06 2007-10-18 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Glycated peptides and methods of use
JP5465008B2 (ja) * 2007-10-30 2014-04-09 パナソニック株式会社 ヘモグロビン及びヘモグロビン誘導体の測定方法、測定キット
EP2265324B1 (de) 2008-04-11 2015-01-28 Sanofi-Aventis Deutschland GmbH Integriertes System zur Messung von Analyten
IT1392250B1 (it) 2008-12-02 2012-02-22 Univ Degli Studi Torino Procedimento e kit per la rivelazione di sangue umano o animale su una superficie.
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8703494B2 (en) * 2009-05-20 2014-04-22 Relia Diagnostic Systems, Llc Systems and methods for determining the percentage of glycated hemoglobin
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
KR101919330B1 (ko) * 2011-06-16 2018-11-19 후지필름 가부시키가이샤 고감도의 면역크로마토그래프 방법 및 면역크로마토그래프용 키트
CN102636638A (zh) * 2012-04-19 2012-08-15 上海蓝怡科技有限公司 基于大粒径磁珠的抗原抗体包被方法
GB201215571D0 (en) * 2012-08-31 2012-10-17 Axis Shield Asa Assay method
CN102998463A (zh) * 2012-11-29 2013-03-27 英科新创(厦门)科技有限公司 一种测量糖化血红蛋白的方法及试剂盒
JP5767362B1 (ja) * 2014-04-25 2015-08-19 田中貴金属工業株式会社 免疫クロマト分析装置、免疫クロマト分析方法及び免疫クロマト分析キット
FR3027395B1 (fr) * 2014-10-17 2016-10-21 Biomerieux Sa Composition pour dosage immuno-enzymatique par immunofluorescence et ses utilisations
CN105137082A (zh) * 2015-07-31 2015-12-09 柏荣诊断产品(上海)有限公司 一种双试剂糖化血红蛋白检测试剂盒
EP3589948A4 (de) * 2017-03-03 2020-12-30 Polymer Technology Systems, Inc. Systeme und verfahren zur enzymatischen a1c-detektion und -quantifizierung
US11703513B2 (en) 2017-08-07 2023-07-18 Polymer Technology Systems, Inc. Systems and methods for enzymatic A1C detection and quantification
CN107991500B (zh) * 2018-01-31 2020-05-12 迈克生物股份有限公司 糖化血红蛋白检测试剂盒
WO2022115705A2 (en) 2020-11-30 2022-06-02 Enigma Biointelligence, Inc. Non-invasive assessment of alzheimer's disease

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4658022A (en) * 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes
US4847209A (en) * 1987-11-09 1989-07-11 Miles Inc. Latex agglutination immunoassay in the presence of hemoglobin
NO890029D0 (no) * 1989-01-04 1989-01-04 Axis Research Nye modifiserte peptider og proteiner for in vitro diagnoser (diabetes).
US5736349A (en) * 1989-09-29 1998-04-07 Nippon Paint Co., Ltd. Magnetic particle and immunoassay using the same
WO1991009678A1 (en) 1989-12-22 1991-07-11 Omni Quest Corporation Organo-metallic coated particles for use in separations
GB9024771D0 (en) * 1990-11-14 1991-01-02 Axis Research Assay
US5840851A (en) * 1993-07-23 1998-11-24 Plomer; J. Jeffrey Purification of hemoglobin
US5985312A (en) 1996-01-26 1999-11-16 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
US5786428A (en) * 1996-03-27 1998-07-28 California Institute Of Technology Adsorbents for amino acid and peptide separation
US6316265B1 (en) * 1997-03-13 2001-11-13 Abbott Laboratories Determination of % glycated hemoglobin
AU7685498A (en) 1997-05-14 1998-12-08 Weixin Tang Fully-coated, uniform-sized metallic particles
US6174734B1 (en) * 1997-10-24 2001-01-16 Abbott Laboratories Measurement of glycated hemoglobin
JP4733335B2 (ja) 2000-08-29 2011-07-27 協和メデックス株式会社 再現性良好な凝集イムノアッセイ法及び試薬
GB0110053D0 (en) * 2001-04-24 2001-06-13 Axis Shield Asa Assay
US7115397B2 (en) * 2003-09-12 2006-10-03 Promega Corporation Methods and kits for purifying his-tagged proteins

Also Published As

Publication number Publication date
EP1624307A3 (de) 2006-10-11
JP2006058295A (ja) 2006-03-02
US20060030050A1 (en) 2006-02-09
EP1624307A2 (de) 2006-02-08
CA2514010A1 (en) 2006-02-03
EP1624307B1 (de) 2008-09-17
AU2005203321A1 (en) 2006-02-23
US7592182B2 (en) 2009-09-22
JP5031208B2 (ja) 2012-09-19
DE602005009769D1 (de) 2008-10-30

Similar Documents

Publication Publication Date Title
DE602005009769D1 (de) Assay zum Nachweis von glykiertem oder glykosyliertem Hämoglobin (HbA1c)
WO2002061129A3 (en) Oligonucleotide identifiers
WO2002001230A3 (en) Rapid and sensitive detection of protein aggregation
ATE540319T1 (de) Verfahren für die bestimmung von fk506
ATE451390T1 (de) Polypeptide zur bindung an das b-lymphozyten- stimulatorische protein (blys)
EA200701211A1 (ru) Полипептиды, которые связываются с br3, и их применение
WO2003102581A3 (en) Assay for glycosylated proteins
WO2000043791A3 (en) Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases
EA201170312A1 (ru) Селективные антитела к гепцидину-25 и их применение
WO2004111081A3 (en) Antigenic peptides of sars coronavirus and uses thereof
WO2004082608A3 (en) Ligands for tgf-beta binding proteins and uses thereof
EP2295979A3 (de) Proteinnachweisreagentien und -verfahren mit Farbstoffen und Dextrinen
DE602005006633D1 (de) Reagenziensatz zum Nachweis von Lupus-Antikoagulant.
MX2021002122A (es) Deteccion por micromuestreo en diabetes.
ATE520028T1 (de) Test zum nachweis von proteinbindung
ATE475098T1 (de) Verfahren zur messung von plasmaspiegeln von pentraxin ptx3
ATE444491T1 (de) Verfahren zur bestimmung von kardiovaskulären risikofaktoren
WO2006056438A3 (de) Protein-biochip zur validierung von bindern
WO2004078783A3 (en) Enzymes involved in apoptosis
ATE547161T1 (de) Verfahren zur quantitativen bestimmung von poloxameren
TW200637830A (en) Erastin and erastin binding proteins, and uses thereof
WO2008002656A3 (en) Methods and materials for in vitro analysis and/or use of membrane-associated proteins, portions thereof or variants thereof
MX2024007267A (es) Anticuerpos anti-pilra, usos de estos y métodos y reactivos relacionados.
WO2007067557A3 (en) Methods for cyclic nucleotide determination
DE50203136D1 (de) Verfahren zum Nachweis von Analyten in Proben mittels Analysenelementen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
REN Ceased due to non-payment of the annual fee